|
Volumn 39, Issue 2, 2007, Pages 558-559
|
Fluvastatin as Co-Medication in Heart Transplant Recipients With Elevated Creatine-Kinase
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
CREATINE KINASE;
CREATININE;
FLUINDOSTATIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMMUNOSUPPRESSIVE AGENT;
SIMVASTATIN;
TRIACYLGLYCEROL;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ARTICLE;
CREATINE KINASE BLOOD LEVEL;
CREATININE BLOOD LEVEL;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
FEMALE;
GRAFT RECIPIENT;
HEART TRANSPLANTATION;
HUMAN;
LIPID BLOOD LEVEL;
MALE;
MYALGIA;
PRIORITY JOURNAL;
SIDE EFFECT;
TRIACYLGLYCEROL BLOOD LEVEL;
ADULT;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
CREATINE KINASE;
DRUG THERAPY, COMBINATION;
FATTY ACIDS, MONOUNSATURATED;
FEMALE;
HEART TRANSPLANTATION;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INDOLES;
MALE;
MIDDLE AGED;
PYRROLES;
SIMVASTATIN;
TRIGLYCERIDES;
|
EID: 33847754275
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2006.12.009 Document Type: Article |
Times cited : (3)
|
References (5)
|